Evidence map›Paper›PMID 29588307›Full record

ArticleCold Spring Harbor molecular case studies2018

Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer.

Jatinder Dhami, Kim M Hirshfield, Shridar Ganesan, Mira Hellmann, Veronica Rojas, Judith K Amorosa, Gregory M Riedlinger, Hua Zhong, Siraj M Ali, Dean Pavlick and 2 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cold Spring Harbor molecular case studies, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Histology-specificGynecologic oncology reports · 2020
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Jatinder Dhami *Department of Medicine, Division of Medical Oncology, Rutgers Cancer Institute of New Jersey/Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA.
Kim M Hirshfield *Department of Medicine, Division of Medical Oncology, Rutgers Cancer Institute of New Jersey/Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA.
Shridar GanesanDepartment of Medicine, Division of Medical Oncology, Rutgers Cancer Institute of New Jersey/Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA.
Mira HellmannDepartment of Obstetrics and Gynecology, Hackensack University Medical Center-Hackensack Meridian Health, John Theurer Cancer Center, Hackensack, New Jersey 07601, USA.
Veronica RojasDepartment of Obstetrics and Gynecology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA.
Judith K AmorosaDepartment of Radiology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA.
Gregory M RiedlingerDepartment of Pathology, Monmouth Medical Center, Long Branch, New Jersey 07740, USA.
Hua ZhongDepartment of Pathology, Monmouth Medical Center, Long Branch, New Jersey 07740, USA.
Siraj M AliFoundation Medicine, Inc. Cambridge, Massachusetts 02141, USA.
Dean PavlickFoundation Medicine, Inc. Cambridge, Massachusetts 02141, USA.
Julia A ElvinFoundation Medicine, Inc. Cambridge, Massachusetts 02141, USA.
Lorna Rodriguez-RodriguezDepartment of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, Rutgers Cancer Institute of New Jersey/Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA.
Rutgers, The State University of New Jersey · USMonmouth Medical Center · USHackensack University Medical Center · USJohnson University · USRutgers Cancer Institute of New Jersey

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Chang S Chan · 1997 to 2026
$94.5M
NCI NIH HHS P30 CA072720
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expression ProfilingGenomicsTranscriptomeBiomarkers, TumorBiopsyClass I Phosphatidylinositol 3-KinasesEndometrial NeoplasmsFemaleHumansImmunohistochemistryMiddle AgedMolecular Targeted TherapyNeoplasm GradingNeoplasm StagingOncogene Proteins, FusionPositron Emission Tomography Computed TomographyBiomarkers, TumorClass I Phosphatidylinositol 3-KinasesFGFR3 protein, humanOncogene Proteins, FusionPIK3CA protein, humanReceptor, Fibroblast Growth Factor, Type 3endometrial carcinoma

Identifiers

PMID29588307
PMCPMC5880253
OpenAlexW2794606638

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.